| 摘要 |
The invention relates to a DNA chip for performing causal diagnosis of hypertension (hypertonia), which enables an early diagnosis and a highly effective therapy that is tailored to each patient and which has the fewest possible side effects. The invention also relates to a DNA chip for developing novel antihypertensive pharmaceutical agents and for stratifying patients in early phases of the clinical testing of novel pharmaceutical agents of this type.
|
